Early-Phase Clinical Trials and Reimbursement Submissions to the Pan-Canadian Oncology Drug Review

Pharmacoeconomics. 2021 Mar;39(3):373-377. doi: 10.1007/s40273-020-00995-3. Epub 2021 Jan 19.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents*
  • Canada
  • Humans
  • Pharmaceutical Preparations*
  • Technology Assessment, Biomedical

Substances

  • Antineoplastic Agents
  • Pharmaceutical Preparations

Grants and funding